Home » Topics » Regulatory » Patents

Patents
RSS

Fujisawa reports selective COX-2 inhibitors

May 28, 1997

Nissan Chem. reveals new antidiabetic agents

May 28, 1997

Chiroscience discloses cytokine inhibitors

May 28, 1997

Leukotriene antagonists from Pfizer

May 28, 1997

Prodrugs of nitrogen mustard with selective antitumor activity

May 27, 1997

Antiviral pyrimidine nucleosides described by Yamasa

May 27, 1997

Natural antitumor compounds described by Banyu

May 27, 1997

Inhibitors of 5alpha-reductase from Kyowa Hakko

May 27, 1997

Opioid antagonists/agonists described by Toray

May 27, 1997

Banyu discovers potent new antitumor agent

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...